Spinal Simplicity Receives FDA Clearance for Use of Its Implants as Treatment for Lumbar Spinal Stenosis

December 17, 2021 / Nueterra Capital Marketing

Spinal Simplicity | A Nueterra Capital Portfolio Company

Nueterra Capital portfolio company Spinal Simplicity announced that its Minuteman family of implants has received Indication for Use (IFU) clearance from the FDA for the treatment of lumbar spinal stenosis. Spinal Simplicity’s Minuteman implant is an interspinous-interlaminar fusion device that provides immobilization and stabilization of the spinal segments. Previously cleared for use in treating degenerative disc disease, spondylolisthesis (slipped vertebra), trauma, and tumors, the new clearance allows patients suffering from lumbar spinal stenosis to have access to this minimally invasive treatment.